vs
Side-by-side financial comparison of Essex Property Trust (ESS) and HUTCHMED (China) Ltd (HCM). Click either name above to swap in a different company.
Essex Property Trust is the larger business by last-quarter revenue ($479.6M vs $270.8M, roughly 1.8× HUTCHMED (China) Ltd). Essex Property Trust runs the higher net margin — 17.9% vs 0.7%, a 17.2% gap on every dollar of revenue. On growth, Essex Property Trust posted the faster year-over-year revenue change (5.5% vs -16.5%).
Essex Property Trust is a publicly traded real estate investment trust that invests in apartments in California and in the Seattle metropolitan area.
HUTCHMED (China) LtdHCMEarnings & Financial Report
HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.
ESS vs HCM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $479.6M | $270.8M |
| Net Profit | $85.7M | $2.0M |
| Gross Margin | 70.0% | 37.7% |
| Operating Margin | 31.7% | -13.2% |
| Net Margin | 17.9% | 0.7% |
| Revenue YoY | 5.5% | -16.5% |
| Net Profit YoY | -71.6% | -83.6% |
| EPS (diluted) | $1.24 | $0.00 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $479.6M | $270.8M | ||
| Q3 25 | $473.3M | — | ||
| Q2 25 | $469.8M | $277.7M | ||
| Q1 25 | $464.6M | $324.5M | ||
| Q4 24 | $454.5M | — | ||
| Q3 24 | $450.7M | — | ||
| Q2 24 | $442.4M | $305.7M | ||
| Q1 24 | $426.9M | — |
| Q4 25 | $85.7M | $2.0M | ||
| Q3 25 | $172.7M | — | ||
| Q2 25 | $231.5M | $455.0M | ||
| Q1 25 | $212.8M | $11.9M | ||
| Q4 24 | $301.7M | — | ||
| Q3 24 | $125.5M | — | ||
| Q2 24 | $99.0M | $25.8M | ||
| Q1 24 | $285.1M | — |
| Q4 25 | 70.0% | 37.7% | ||
| Q3 25 | 69.2% | — | ||
| Q2 25 | 70.7% | 0.1% | ||
| Q1 25 | 69.6% | 48.0% | ||
| Q4 24 | 70.0% | — | ||
| Q3 24 | 69.5% | — | ||
| Q2 24 | 70.8% | 41.1% | ||
| Q1 24 | 69.7% | — |
| Q4 25 | 31.7% | -13.2% | ||
| Q3 25 | 44.5% | — | ||
| Q2 25 | 59.5% | -1.3% | ||
| Q1 25 | 55.3% | -5.0% | ||
| Q4 24 | 67.0% | — | ||
| Q3 24 | 28.6% | — | ||
| Q2 24 | 31.1% | -9.0% | ||
| Q1 24 | 31.0% | — |
| Q4 25 | 17.9% | 0.7% | ||
| Q3 25 | 36.5% | — | ||
| Q2 25 | 49.3% | 163.8% | ||
| Q1 25 | 45.8% | 3.7% | ||
| Q4 24 | 66.4% | — | ||
| Q3 24 | 27.8% | — | ||
| Q2 24 | 22.4% | 8.4% | ||
| Q1 24 | 66.8% | — |
| Q4 25 | $1.24 | $0.00 | ||
| Q3 25 | $2.56 | — | ||
| Q2 25 | $3.44 | $0.52 | ||
| Q1 25 | $3.16 | $0.01 | ||
| Q4 24 | $4.00 | — | ||
| Q3 24 | $1.84 | — | ||
| Q2 24 | $1.45 | $0.03 | ||
| Q1 24 | $4.25 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $76.2M | $1.4B |
| Total DebtLower is stronger | — | $93.2M |
| Stockholders' EquityBook value | $5.5B | $1.2B |
| Total Assets | $13.2B | $1.8B |
| Debt / EquityLower = less leverage | — | 0.08× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $76.2M | $1.4B | ||
| Q3 25 | $66.0M | — | ||
| Q2 25 | $58.7M | $1.4B | ||
| Q1 25 | $98.7M | $836.1M | ||
| Q4 24 | $66.8M | — | ||
| Q3 24 | $71.3M | — | ||
| Q2 24 | $55.2M | $802.5M | ||
| Q1 24 | $499.0M | — |
| Q4 25 | — | $93.2M | ||
| Q3 25 | $6.4B | — | ||
| Q2 25 | $6.4B | $93.4M | ||
| Q1 25 | $6.8B | $82.8M | ||
| Q4 24 | — | — | ||
| Q3 24 | $6.4B | — | ||
| Q2 24 | $6.2B | $82.1M | ||
| Q1 24 | $6.6B | — |
| Q4 25 | $5.5B | $1.2B | ||
| Q3 25 | $5.6B | — | ||
| Q2 25 | $5.6B | $1.2B | ||
| Q1 25 | $5.6B | $759.9M | ||
| Q4 24 | $5.5B | — | ||
| Q3 24 | $5.4B | — | ||
| Q2 24 | $5.5B | $740.1M | ||
| Q1 24 | $5.5B | — |
| Q4 25 | $13.2B | $1.8B | ||
| Q3 25 | $13.2B | — | ||
| Q2 25 | $13.2B | $1.8B | ||
| Q1 25 | $13.2B | $1.3B | ||
| Q4 24 | $12.9B | — | ||
| Q3 24 | $12.6B | — | ||
| Q2 24 | $12.5B | $1.3B | ||
| Q1 24 | $12.9B | — |
| Q4 25 | — | 0.08× | ||
| Q3 25 | 1.15× | — | ||
| Q2 25 | 1.14× | 0.08× | ||
| Q1 25 | 1.22× | 0.11× | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.18× | — | ||
| Q2 24 | 1.13× | 0.11× | ||
| Q1 24 | 1.19× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.1B | $8.2M |
| Free Cash FlowOCF − Capex | — | $3.4M |
| FCF MarginFCF / Revenue | — | 1.2% |
| Capex IntensityCapex / Revenue | — | 1.8% |
| Cash ConversionOCF / Net Profit | 12.53× | 4.21× |
| TTM Free Cash FlowTrailing 4 quarters | — | $-96.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.1B | $8.2M | ||
| Q3 25 | $342.6M | — | ||
| Q2 25 | $216.1M | $-72.9M | ||
| Q1 25 | $281.5M | $40.3M | ||
| Q4 24 | $1.1B | — | ||
| Q3 24 | $316.2M | — | ||
| Q2 24 | $218.9M | $-39.8M | ||
| Q1 24 | $314.9M | — |
| Q4 25 | — | $3.4M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $-82.2M | ||
| Q1 25 | — | $32.5M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $-49.9M | ||
| Q1 24 | — | — |
| Q4 25 | — | 1.2% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -29.6% | ||
| Q1 25 | — | 10.0% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -16.3% | ||
| Q1 24 | — | — |
| Q4 25 | — | 1.8% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 3.3% | ||
| Q1 25 | — | 2.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 3.3% | ||
| Q1 24 | — | — |
| Q4 25 | 12.53× | 4.21× | ||
| Q3 25 | 1.98× | — | ||
| Q2 25 | 0.93× | -0.16× | ||
| Q1 25 | 1.32× | 3.38× | ||
| Q4 24 | 3.54× | — | ||
| Q3 24 | 2.52× | — | ||
| Q2 24 | 2.21× | -1.54× | ||
| Q1 24 | 1.10× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
